Sort by
Refine Your Search
-
with a research program focused on mechanistic questions that are related to genome regulation, RNA metabolism, or protein homeostasis. We are especially interested in candidates using cutting-edge
-
you the space you need to attend to your personal goals, meet your family obligations, and pursue your professional development. We also have a variety of site-specific plans and programmes in place
-
immunoengineering. This position is part of our newly funded ERC Advanced Grant, which aims to develop genetically engineered feedback control circuits in human T cells to tackle challenging diseases. The successful
-
develop distributed and addressable robotic actuating materials that demonstrate multifunctionality through the broad bandwidth of light. The Robotic Materials group headed by Prof. Hedan Bai at Department
-
of Competence in Research (NCCR) “SPIN: Spin Qubits in Silicon" supported by the Swiss National Science Foundation. The NCCR SPIN is developing fundamental elements of scalable quantum computing with spins qubits
-
internationally distinguished scientific track record in a core area of ETH Zurich. As an experienced leader in an academic or research organisation, you can shape and lead the strategic development of ETH Zurich
-
they need today and for generations to come. Creating a world where we all have more time with the people we love. That’s what makes us Roche. In Roche’s Pharmaceutical Research and Early Development
-
-state materials. The newly appointed Assistant Professor should hold a Ph.D. degree or equivalent qualification and is expected to establish an internationally recognized research program in the field
-
funds and published under the DORA principles. Lead a research group, coordinate its research with that developed by other groups of the Department, in compliance with legal and ethical regulations and in
-
. Support high-quality trial delivery by managing country-specific risks and collaborating with affiliate teams and leadership to align local needs with global clinical development goals and regional